FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration has announced a new, aggressive timeline for AI adoption across its centers ... According to a statement, the FDA plans to further expand its AI capabilities to focus ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The Food and Drug Administration (FDA) plans to launch generative AI across all of its centers by June 30. The announcement follows the appointment of the agency’s first chief AI officer, Jeremy Walsh ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

READ: Amazon unveils plans for AI supercomputer with Apple, Anthropic as first users (December 4, 2024) Jinzhong (Jin) Liu, Deputy Director, Office of Drug Evaluation Sciences, Office of New ...

AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients and analysing data, among other uses. While ...